Physician

David Peter Cosgrove, M.D.

According to 2025 Medicare claims, David Cosgrove, M.D. (NPI: 1861567562) practices medical oncology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Clark, WA. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 98684-6930. Cosgrove is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Cosgrove's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 472 traditional Medicare patients, billed 94,326 HCPCS/CPT codes, and received $1,602,176 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,223 prescription claims across 193 beneficiaries totaling $3,883,658 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 22 claims. Open Payments data shows 64 records totaling $132,953. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $150,825 to $1,602,176. Similarly, Part D prescription costs have risen steadily, from $233,809 to $3,883,658. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	179	8,946	$150,825
2016	318	68,131	$883,602
2017	378	76,594	$868,980
2018	439	78,573	$1,051,870
2019	408	84,824	$1,133,894
2020	356	68,389	$1,062,217
2021	597	90,798	$1,470,236
2022	472	123,205	$1,513,071
2023	432	86,590	$1,142,998
2024	472	94,326	$1,602,176

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	60	186	$233,809
2016	120	620	$804,743
2017	156	1,067	$1,719,221
2018	207	1,162	$2,256,007
2019	186	1,178	$2,020,668
2020	167	911	$977,222
2021	159	935	$1,541,381
2022	217	1,121	$2,152,596
2023	192	1,056	$2,190,034
2024	193	1,223	$3,883,658

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$3,772
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$3,737

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	139	322	$94
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	93	179	$12
80053	Blood test, comprehensive group of blood chemicals	170	596	$10
36415	Insertion of needle into vein for collection of blood sample	149	440	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	172	618	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	46	1,288	$567,504
Erleada	Apalutamide	38	1,140	$545,014
Tibsovo	Ivosidenib	12	360	$404,852
Imbruvica	Ibrutinib	24	672	$369,932
Piqray	Alpelisib	11	308	$243,655

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$2,335
B4036	Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$1,403

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$195	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	58	$132,759	BioNTech SE
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Peter Cosgrove, M.D.?

Tedicare shows public-source Medicare data for David Peter Cosgrove, M.D. (NPI 1861567562), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Peter Cosgrove, M.D. have ACO affiliation data?

David Peter Cosgrove, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David Peter Cosgrove, M.D.?

David Peter Cosgrove, M.D. is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does David Peter Cosgrove, M.D. have Open Payments data?

David Peter Cosgrove, M.D. has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.